Vital Farms NASDAQ: VITL reported third-quarter results that improved sequentially from the prior quarter but declined from a year earlier, as the specialty egg producer continued to adjust supply and lowered its full-year outlook amid softer-than-expected seasonal demand.
The company reported third-quarter net revenue of $182.2 million, up 10% from the second quarter but down $16.8 million, or 8.4%, from the year-ago period. Chief Financial Officer Thilo Wrede said the year-over-year decline primarily reflected $14.3 million of lower price and mix and $2.2 million of lower volume excluding breaker and wholesale channels.
Gross profit was $42.1 million, representing a gross margin of 23.1%, an improvement of more than 16 percentage points from the second quarter. Adjusted EBITDA was $1.5 million, compared with a $26.6 million adjusted EBITDA loss in the prior quarter.
Supply Actions Support Sequential Margin Recovery
Executive Chairperson, President and CEO Russell Diez-Canseco said the company’s recovery from the second quarter was supported primarily by changes to farmer contracts that gave Vital Farms more control over supply.
The amendments have been implemented, and the volume sent to breaker and wholesale channels declined 59% from the second quarter. Diez-Canseco described the reduction in those channels as the largest contributor to the company’s margin recovery.
Wrede said breaker volume represented about an $8 million impact to EBITDA in the third quarter, compared with a $21 million impact in the second quarter. He said the company expects to make further progress managing excess supply, although some excess volume is still expected to be sold through breaker and wholesale channels in the fourth quarter.
Vital Farms also said it completed efficiency actions announced in May and July that are expected to reduce its annualized SG&A run rate by approximately $6 million to $7 million. Third-quarter SG&A expense was $38.1 million, down $6.3 million, or 14%, from the prior-year period.
Shipping and distribution expense increased to $11.7 million from $9.2 million a year earlier, driven primarily by higher fuel rates and unfavorable line-haul rates.
Company Lowers Full-Year Sales and EBITDA Outlook
Vital Farms reduced its full-year net-sales outlook to about $730 million, from a prior range of $775 million to $800 million. The company also lowered its adjusted EBITDA outlook to about a $15 million loss, compared with prior guidance for adjusted EBITDA ranging from breakeven to a $10 million gain.
Management cited three factors behind the lower fourth-quarter expectations:
- Demand has not shown the normal seasonal build into the holiday period, with retailers buying closer to immediate needs rather than building inventory ahead of Thanksgiving.
- Some recently secured distribution reached store shelves several weeks later than expected, reducing the number of selling weeks in the quarter.
- The company no longer assumes conventional egg prices will rise seasonally into the holidays, which would ordinarily narrow the price gap between Vital Farms products and conventional eggs.
For the fourth quarter, Vital Farms expects shell egg distribution to remain above 175 total distribution points, or TDPs, in Circana MULO+ data. The company expects fourth-quarter unit velocity of approximately 25.9 equivalent units per store per week per item, compared with 25.3 in the third quarter. Dollar velocity is expected to decline to approximately $200 per store per week per item from roughly $205 in the third quarter, reflecting increased promotional activity and slower initial turns at newer distribution points.
Vital Farms also expects to generate $3 million to $4 million in butter net sales during the fourth quarter as it sells its remaining bulk and finished-goods butter inventory. Wrede said butter is margin dilutive and that exiting the business by year-end could support margin improvement in 2027.
Pricing View Shifts Toward Private-Label Competition
Diez-Canseco said the company believes its performance this year has been affected largely by households that tried Vital Farms products when avian influenza compressed price differences across the egg aisle in 2024 and 2025, then returned to lower-priced private-label products as egg supply normalized.
Store-brand egg prices have returned to approximately $2 per dozen, according to management, and Vital Farms said its price premium relative to other outdoor-access brands is now near where it stood in the third quarter of 2023, the last period management characterized as a fully supplied market.
“Our pricing is actually not excessively high,” Diez-Canseco said during the question-and-answer session. He said the company now believes that most of the lost volume came from light buyers returning to private-label offerings rather than customers switching to branded competitors.
As a result, the company said its pricing approach is no longer centered on narrowing gaps with branded competitors. Instead, management said promotions will be used selectively to encourage product trial rather than broadly to drive short-term volume.
Despite the softer comparison with 2025, Diez-Canseco said the company’s third-quarter revenue was about 65% above third-quarter 2023 levels, while velocities were approximately unchanged despite nearly 60% more distribution points. Vital Farms ended the third quarter with a record 7.2% dollar share and 2.3% volume share of shell eggs in Circana MULO+ data.
Capacity Spending Paused; Long-Term Targets Withdrawn
The company ended the quarter with $84 million in cash and $117.6 million of outstanding debt. Capital expenditures totaled $14.3 million in the third quarter and $51.7 million year to date.
At its Vital Crossroads facility, Vital Farms has largely completed work needed to enclose the building and plans to pause construction after completing the frame, walls and roof. Full-year capital spending guidance remains $70 million to $75 million, down from the $140 million to $150 million projected in February.
Diez-Canseco said the company’s existing Egg Central Station facility is operating with high uptime and fill rates following the addition of a third production line. He said the facility has a run-rate capacity of roughly $1 billion in net revenue, though additional capacity would likely be needed before the company reaches that annualized level because of seasonality and distribution timing.
Vital Farms also withdrew its 2030 financial targets, saying it intends to focus on near-term execution, margin expansion and profitability before revisiting longer-term targets. The company is additionally conducting a limited test of a free-range egg product, which management said could address a larger portion of the egg market, though it does not expect the pilot to materially affect 2027 results.
About Vital Farms (NASDAQ:VITL)
Vital Farms, Inc is a food company that produces and markets pasture-raised eggs and other ethically sourced food products. Its offerings include pasture-raised eggs, butter, hard-boiled eggs and ghee, sold under the Vital Farms brand.
Founded in 2007, the company works with a network of family farms and focuses on animal welfare, outdoor access and supply-chain transparency. Vital Farms products are distributed primarily through grocery retailers and other food channels across the United States.
Vital Farms is headquartered in Austin, Texas.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.